cyclohexanol has been researched along with Hypertension in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghormode, D; Grover, S; Somaiya, M | 1 |
| Bhandary, RP; Munoli, RN; Praharaj, SK; Selvaraj, AG | 1 |
| Greenberg, H; Wang, J | 1 |
| Kang, P; Lee, HS; Min, SS; Moon, HK; Seol, GH | 1 |
| Kallikazaros, IE; Katsi, VK; Makris, T; Marketou, M; Stefanadis, CI; Tousoulis, D; Vamvakou, G; Vardas, P | 1 |
| Austin, PC; Gomes, T; Ho, JM; Juurlink, DN; Mamdani, M; Straus, SE | 1 |
| Boucher, M; Cheng, RF; Fayyad, R; Guico-Pabia, CJ; Sporn, J; Thase, ME; Tourian, KA | 1 |
| Brozoski, DT; Dean, C; Hillard, CJ; Hopp, FA; Seagard, JL | 1 |
| Rakun, R; Ružić, K; Sabljić, V | 1 |
| Bennett, BL; Friedman, GC; Lim, AK; Ma, FY; Nikolic-Paterson, DJ; Ozols, E; Tesch, GH; Young, MJ | 1 |
| Jha, A; Tomar, R | 1 |
| Crystal, S; Olfson, M; Sambamoorthi, U; Walkup, JT | 1 |
| Baudendistel, TE; Khurana, RN | 1 |
| Ferrier, N; Harrison, CL; Young, AH | 1 |
| Begley, AE; Johnson, EM; Mulsant, BH; Pollock, BG; Reynolds, CF; Weber, E; Whyte, E | 1 |
| Ahmed, S; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Musgnung, J; Nemeroff, CB; Ninan, PT; Pedersen, RD; Rothschild, AJ; Schatzberg, AF; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM | 1 |
| Kornstein, SG | 1 |
| Gormly, LJ; Pleak, RR | 1 |
| Feighner, JP | 1 |
| López-Martín, JM; Martínez Mir, I; Palop Larrea, V; Pastor Navarro, MC | 1 |
| Ansseau, M | 1 |
| Thase, ME | 1 |
| MacIver, DH; Partridge, SJ; Solanki, T | 1 |
5 review(s) available for cyclohexanol and Hypertension
| Article | Year |
|---|---|
Novel antidepressant drugs, arterial hypertension and cardiovascular disease.
Topics: Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Cardiovascular System; Cyclohexanols; Humans; Hypertension; Patents as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis.
Topics: Adult; Antidepressive Agents; Blood Pressure; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Cardiovascular safety in depressed patients: focus on venlafaxine.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Heart Conduction System; Humans; Hypertension; Hypotension, Orthostatic; Incidence; Placebos; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1995 |
Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depressive Disorder; Diastole; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Posture; Proportional Hazards Models; Regression Analysis; Venlafaxine Hydrochloride | 1998 |
2 trial(s) available for cyclohexanol and Hypertension
| Article | Year |
|---|---|
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
Topics: Age of Onset; Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Monitoring; Electrocardiography; Female; Guidelines as Topic; Heart Rate; Humans; Hypertension; Hypotension, Orthostatic; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tachycardia; Venlafaxine Hydrochloride | 2006 |
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Double-Blind Method; Female; Fluoxetine; Gastrointestinal Diseases; Headache; Humans; Hypertension; Male; Middle Aged; Respiratory Tract Infections; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
16 other study(ies) available for cyclohexanol and Hypertension
| Article | Year |
|---|---|
Venlafaxine-associated hyponatremia presenting with catatonia.
Topics: Antidepressive Agents, Second-Generation; Catatonia; Cyclohexanols; Female; Humans; Hypertension; Hyponatremia; Middle Aged; Venlafaxine Hydrochloride | 2013 |
Desvenlafaxine-induced worsening of hypertension.
Topics: Antidepressive Agents; Anxiety; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Hypertension; Middle Aged | 2013 |
Status cataplecticus precipitated by abrupt withdrawal of venlafaxine.
Topics: Aged; Cataplexy; Cyclohexanols; Electroencephalography; Female; Humans; Hypertension; Narcolepsy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2013 |
Effects of 1,8-cineole on hypertension induced by chronic exposure to nicotine in rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cyclohexanols; Eucalyptol; Eucalyptus; Hypertension; Male; Monoterpenes; Nicotine; Nifedipine; Nitric Oxide; Nitrites; Oxidative Stress; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley | 2014 |
Adverse cardiac events in older patients receiving venlafaxine: a population-based study.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cohort Studies; Comorbidity; Cyclohexanols; Drug Interactions; Female; Heart Failure; Humans; Hypertension; Male; Myocardial Infarction; Ontario; Retrospective Studies; Risk Factors; Sertraline; Tachycardia; Venlafaxine Hydrochloride | 2014 |
Differential endocannabinoid regulation of baroreflex-evoked sympathoinhibition in normotensive versus hypertensive rats.
Topics: Analgesics; Animals; Arachidonic Acids; Baroreflex; Blood Pressure; Cannabinoid Receptor Modulators; Cyclohexanols; Endocannabinoids; GABA Antagonists; Hypertension; Male; Protein Binding; Pyridazines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Cannabinoid, CB1; Solitary Nucleus; Sympathetic Nervous System; Time Factors; Tritium | 2009 |
Venlafaxine withdrawal syndrome.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Ischemic Attack, Transient; Retreatment; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2011 |
Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
Topics: Albuminuria; Animals; Blood Pressure; Body Weight; Cyclohexanols; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Early Medical Intervention; Hypertension; Hypertrophy; Immunohistochemistry; Inhibitory Concentration 50; Male; MAP Kinase Kinase 4; Protein Kinase Inhibitors; Purines; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction | 2011 |
Interaction between ECT and venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Atenolol; Combined Modality Therapy; Cyclohexanols; Depression; Electroconvulsive Therapy; Fatal Outcome; Female; Humans; Hypertension; Venlafaxine Hydrochloride | 2002 |
Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
Topics: Age Factors; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depression; Diabetes Mellitus; Fee-for-Service Plans; Female; Health Status; Heart Diseases; Humans; Hypertension; Male; Medicare; Monoamine Oxidase Inhibitors; Multivariate Analysis; Racial Groups; Sample Size; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socioeconomic Factors; Venlafaxine Hydrochloride | 2003 |
Hypertensive crisis associated with venlafaxine.
Topics: Adult; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Disulfiram; Drug Interactions; Humans; Hypertension; Venlafaxine Hydrochloride | 2003 |
Tolerability of high-dose venlafaxine in depressed patients.
Topics: Adult; Aged; Blood Pressure; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Formularies as Topic; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; United Kingdom; Venlafaxine Hydrochloride | 2004 |
Effects of venlafaxine treatment for ADHD in a child.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Cyclohexanols; Female; Humans; Hypertension; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
[Pastillas Juanola and arterial hypertension].
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyclohexanols; Drug Combinations; Endometriosis; Ethinyl Estradiol; Eucalyptol; Female; Humans; Hypertension; Menthol; Monoterpenes; Norpregnenes; Plant Extracts; Self Medication; Tablets; Terpenes; Time Factors | 1997 |
[Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
Topics: Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Drug Administration Schedule; Humans; Hypertension; Nausea; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride | 1998 |
A depressed myocardium.
Topics: Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Chest Pain; Cyclohexanols; Electrocardiography; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tachycardia, Sinus; Venlafaxine Hydrochloride; Ventricular Function, Left | 2000 |